Immucor, Inc.
Immucor, Inc., a leading player in the transfusion and transplantation diagnostics industry, is headquartered in the United States. Founded in 1982, the company has established itself as a pioneer in developing innovative solutions for blood banks and hospitals, focusing on immunohematology and molecular diagnostics. With a strong presence in North America, Europe, and Asia, Immucor offers a range of core products, including automated blood typing systems and antibody screening tests, which are distinguished by their accuracy and efficiency. The company’s commitment to advancing patient safety and improving laboratory workflows has solidified its market position, making it a trusted partner in the healthcare sector. Notable achievements include numerous regulatory approvals and a robust portfolio of patented technologies that enhance the reliability of transfusion practices.
DitchCarbon Score
How does Immucor, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Immucor, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Immucor, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company is a current subsidiary of Werfen, S.A., which may influence its climate commitments and performance metrics. As a subsidiary, Immucor's climate strategies and emissions data may be aligned with those of Werfen, S.A. However, specific details regarding emissions, such as Scope 1, 2, or 3, and any significant reduction achievements or targets, are not disclosed. In the absence of specific emissions data or reduction initiatives, it is important to note that many companies in the healthcare and diagnostics sector are increasingly focusing on sustainability and carbon neutrality. Immucor may be expected to follow industry trends and best practices in addressing climate change, although specific commitments or actions have not been detailed.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Immucor, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
